Compounded medicine for wholely preventing and treating cardio-cerebral blood vessel diseases and use thereof
A compound technology for cardiovascular and cerebrovascular diseases, applied in the field of chemical drugs, can solve the problems of incompetent prevention and treatment of cardiovascular and cerebrovascular diseases, and achieve the effect of preventing cardiovascular and cerebrovascular events, preventing further occurrence, and protecting cardiovascular and cerebrovascular diseases
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0005] Example 1: The compound medicine consists of 0.5 mg of 17β estradiol, 0.3 mg of medroxyprogesterone, 2.5 mg of simvastatin, 2.0 mg of metoprolol, 0.5 mg of amlodipine, 200 mg of metformin, and 75 mg of aspirin Made into combination preparations, according to oral preparations (common tablets, dispersible tablets, film-coated tablets, sublingual tablets, orally disintegrating tablets, enteric-coated tablets, sustained-release tablets, immediate-release tablets, controlled-release tablets, hard capsules, enteric tablets, etc. Dissolving capsules, sustained-release capsules, etc.) preparation process is carried out. For early menopausal women. Control blood pressure, blood lipids, and blood sugar in an ideal state (blood pressure: 115 / 70mmHg; LDL_C: 1.0mmol / l; blood sugar: <6.0mmol / l). Control metabolic syndrome, monitor sex hormone levels.
Embodiment 2
[0006] Example 2: The compound medicine consists of 0.5 mg of 17β estradiol, 0.3 mg of medroxyprogesterone, 5 mg of simvastatin, 2.0 mg of metoprolol, 0.5 mg of amlodipine, 20 mg of acarbose, and aspirin 100mg made into combination preparations, according to oral preparations (common tablets, dispersible tablets, film-coated tablets, sublingual tablets, orally disintegrating tablets, enteric-coated tablets, sustained-release tablets, immediate-release tablets, controlled-release tablets, hard capsules, Enteric-coated capsules, sustained-release capsules, etc.) preparation process is carried out. For late menopausal women. Control blood pressure, blood lipids, and blood sugar in an ideal state (blood pressure: 115 / 70mmHg; LDL_C: 1.0mmol / l; blood sugar: <6.0mmol / l). Control metabolic syndrome, monitor sex hormone levels.
Embodiment 3
[0007] Embodiment 3: This compound medicine is made of soybean isoflavone 300mg and / or 17β estrogen 0.05mg, simvastatin 2.5mg, metoprolol 2.0mg, amlodipine 0.5mg, pioglitazone 10mg, aspirin 40mg Combination preparations, according to oral preparations (common tablets, dispersible tablets, film-coated tablets, sublingual tablets, orally disintegrating tablets, enteric-coated tablets, sustained-release tablets, immediate-release tablets, controlled-release tablets, hard capsules, enteric-coated tablets, etc. Capsules, sustained-release capsules, etc.) preparation process is carried out. For adult male high-risk groups. Control blood pressure, blood lipids, and blood sugar in an ideal state (blood pressure: 115 / 70mmHg; LDL_C: 1.0mmol / l; blood sugar: <6.0mmol / l). Control metabolic syndrome, monitor sex hormone levels.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com